Trulieve Cannabis stock has seen its consensus analyst price target edge down slightly from $19.16 to $18.87 in recent market updates. While this change appears modest, it reflects a blend of cautious ...
Trulieve Cannabis reported strong financial results for Q3 2025 with increasing revenues and free cash flow. The federal government has reopened with a new funding bill, which included a ban on THC ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback